Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,433,698 results for ""Drug development""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Therapeutic orphans, off-label, pediatric drug development: towards reasonable pharmacotherapy for minors.

  • Authors : Rose K; Klausrose Consulting, Pediatric Drug Developent & More, Riehen, Switzerland.; Grant-Kels JM

Subjects: Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Off-Label Use*/Off-Label Use*/Off-Label Use*/legislation & jurisprudence ; Orphan Drug Production*/Orphan Drug Production*/Orphan Drug Production*/legislation & jurisprudence

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Dec; Vol. 25 (18), pp. 2375-2384. Date of Electronic Publication: 2024 Nov 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice.

  • Authors : Kulesza A; Novadiscovery, 1 Place Giovanni Verrazzano, 69009, Lyon, France. .; Couty C

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Dec; Vol. 51 (6), pp. 581-604. Date of Electronic Publication: 2024 Jun 21.Publisher: Springer Country of Publication: United States NLM ID: 101096520 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

New Horizons of Model Informed Drug Development in Rare Diseases Drug Development.

  • Authors : Mitra A; Clinical Pharmacology, Kura Oncology Inc., Boston, Massachusetts, USA.; Tania N

Subjects: Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy ; Drug Development*/Drug Development*/Drug Development*/methods; Humans

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Dec; Vol. 116 (6), pp. 1398-1411. Date of Electronic Publication: 2024 Jul 11.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

  • Authors : Sawant-Basak A; Clinical Pharmacology and Pharmacometrics, AstraZeneca, Waltham, MA, USA.; Urva S

Subjects: Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods ; Pharmacology, Clinical*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 902-913. Date of Electronic Publication: 2024 Jul 07.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Advocating for drug development in newborn infants.

  • Authors : Allegaert K; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Drug Development*/Drug Development*/Drug Development*/standards; Humans

  • Source: Early human development [Early Hum Dev] 2024 Dec; Vol. 199, pp. 106136. Date of Electronic Publication: 2024 Oct 29.Publisher: Elsevier Country of Publication: Ireland NLM ID: 7708381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6232

Record details

Read More Add to Saved list
×
Academic Journal

Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases.

  • Authors : Neves-Zaph S; Translational Disease Modeling, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey, USA.; Kaddi C

Subjects: Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy ; Drug Development*/Drug Development*/Drug Development*/methods; Humans

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Dec; Vol. 116 (6), pp. 1442-1451. Date of Electronic Publication: 2024 Sep 28.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacogenomics and pediatric drug development: science and political power. A narrative review.

Subjects: Pharmacogenetics*/Pharmacogenetics*/Pharmacogenetics*/methods ; Drug Development*/Drug Development*/Drug Development*/legislation & jurisprudence ; Drug Development*/Drug Development*/Drug Development*/methods

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Dec; Vol. 25 (18), pp. 2367-2373. Date of Electronic Publication: 2024 Sep 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers.

  • Authors : Ahmed MA; Quantitative Clinical Pharmacology, Takeda Development Center, Cambridge, Massachusetts, USA.; Krishna R

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy; Animals

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Dec; Vol. 116 (6), pp. 1412-1432. Date of Electronic Publication: 2024 Aug 16.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

A standing platform for cancer drug development using ctDNA-based evidence of recurrence.

  • Authors : Medford AJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Subjects: Circulating Tumor DNA*/Circulating Tumor DNA*/Circulating Tumor DNA*/genetics ; Circulating Tumor DNA*/Circulating Tumor DNA*/Circulating Tumor DNA*/blood ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Nature reviews. Cancer [Nat Rev Cancer] 2024 Nov; Vol. 24 (11), pp. 810-821. Date of Electronic Publication: 2024 Sep 30.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Which experimental factors govern successful animal-to-human translation in multiple sclerosis drug development? A systematic review and meta-analysis.

  • Authors : Berg I; Center for Reproducible Science, University of Zurich, Zurich, Switzerland; Clinical Neuroscience Center, University of Zurich, Zurich, Switzerland.

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Drug Development* ; Disease Models, Animal*

  • Source: EBioMedicine [EBioMedicine] 2024 Dec; Vol. 110, pp. 105434. Date of Electronic Publication: 2024 Nov 07.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,433,698 results for ""Drug development""